I think price-wise we can (I believe successful AGs can still command a slightly higher price than Generics) but since the Generics have so many products and connections with the pharmacies, that I have always thought it would be tough slough.
It is the CVS Caremark decision that makes me wonder if an AG might make sense. Let me explain. CVS Caremark has stopped brand on the formulary (commercial) but although I could be wrong I believe they cover GV no matter the manufacturer. So they would automatically cover an AG. Willing yo stand corrected on this.
Market Data 
Markets 
AI
